[Influence of gypenoside on serum lipoprotein and atherosclerosis in hyperlipidaemia animals].
The result of the study indicates that gypenoside (GP, i.g.) can suppress the rise of serum cholesterol (CHO) and triglyceride (TRIG) in hyperlipidaemia mice and lower the content of CHO, TRIG and LDL in hyperlipidaemia quails. The study also shows that GP has a protective effect on diffuse lipoidosis in liver and atherosclerosis in hyperlipidaemia quails, and that GP can lower the lipoprotein levels in hyperlipidaemia animals.
Department of Biochemistry Pharmacology, Beijing Medical University.
G
G
Qi
L
L
Zhang
C
C
Li
D000818:Animals; D001161:Arteriosclerosis / Q000517:prevention & control*; D002784:Cholesterol / Q000097:blood; D005260:Female; D006949:Hyperlipidemias / Q000097:blood*; D000960:Hypolipidemic Agents / Q000494:pharmacology*; D008077:Lipoproteins, LDL / Q000097:blood; D008297:Male; D051379:Mice; D011784:Quail; D011897:Random Allocation; D012503:Saponins / Q000494:pharmacology*; D014280:Triglycerides / Q000097:blood
D000960:Hypolipidemic Agents; D008077:Lipoproteins, LDL; D012503:Saponins; D014280:Triglycerides; C077955:gypenoside IX; D002784:Cholesterol